Stromal sarcoma of the breast is a very rare disease accounting for 0.03%of primary breast malignant tumors. From 1995 to 2014, 384 patients with primary breast malignant tumors underwent resection at our institution, of which 2 cases(0.5%) were stromal sarcoma of the breast. Case 1: A woman aged in her 50's presented with a painful lump spanning the right breast identified 7-8 months previously by palpation. The patient first visited the outpatient department at our hospital when the lump gradually increased in size and bleeding from the breast was observed. The tumor measured 8 cm in its greatest dimension and it was elastic soft with a smooth surface, exhibited sphericity, and existed in combination with a partial skin ulcer. Biopsy indicated possibility of stromal sarcoma; therefore, simple mastectomy was performed and the patient was pathologically diagnosed with stromal sarcoma. Presently, the patient is alive and recurrence-free 3 years after the surgery. Case 2: A woman aged in her 80's presented with a left breast tumor identified 4-5 days previously via palpation. The patient visited a general practitioner who referred her to our hospital. The tumor measured 1.6 cm in its greatest dimension and it was elastic hard, irregular in shape, and exhibited dimpling. Biopsy indicated the possibility of malignancy; therefore, a partial resection was performed and the patient was pathologically diagnosed with stromal sarcoma. After 6 months, another lesion was detected and extirpation was performed. A recurrent lesion was detected after 7 months and extirpation was performed again. Presently, the patient is alive and recurrence-free 17 months after the third surgery. In stromal sarcoma of the breast, surgical resection with a negative margin is the only curative treatment. Tumor resection should be planned carefully and the possibility of sarcoma in breast tumors with atypical features as breast cancer should be considered.

Download full-text PDF

Source

Publication Analysis

Top Keywords

stromal sarcoma
28
sarcoma breast
16
breast
10
sarcoma
8
primary breast
8
breast malignant
8
malignant tumors
8
case woman
8
woman aged
8
palpation patient
8

Similar Publications

Purpose: Less than 5% of GI stromal tumors (GISTs) are driven by the loss of the succinate dehydrogenase (SDH) complex, resulting in a pervasive DNA hypermethylation pattern that leads to unique clinical features. Advanced SDH-deficient GISTs are usually treated with the same therapies targeting KIT and PDGFRA receptors as those used in metastatic GIST. However, these treatments display less activity in the absence of alternative therapeutic options.

View Article and Find Full Text PDF

Background: Ewing sarcoma is an EWSR1-rearranged aggressive malignancy that occurs commonly in bone and has small round blue cell morphology. A diagnostic challenge is presented in the cases of extraskeletal Ewing sarcoma involving solid organs, such as the uterus.

Case Report And Brief Literature Review: We present the case of a 54-year-old female with a large pelvic mass connected to the uterine cornua and retroperitoneal soft tissue.

View Article and Find Full Text PDF

Primary Prostatic Stromal Sarcoma: A Case Report and Review of the Literature.

Medicina (Kaunas)

November 2024

Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara 06620, Türkiye.

: Primary prostatic stromal sarcoma is an exceptionally rare urological malignancy, constituting less than 0.1% of all prostatic cancers. It poses a significant clinical challenge due to its aggressive behavior and poor prognosis.

View Article and Find Full Text PDF

Clinical reliability assessment of large language models is necessary due to their increasing use in healthcare. This study assessed the performance of ChatGPT-3.5 and ChatGPT-4 in answering questions deducted from the German evidence-based S3 guideline for adult soft tissue sarcoma (STS).

View Article and Find Full Text PDF

Background: Textbook outcome (TO) has been utilized to assess the quality of surgical care. This study aimed to define TO rates for minimally invasive gastric gastrointestinal stromal tumor (GIST) resections in a bi-institutional cohort.

Methods: Patients with gastric GIST (≤ 5 cm) who underwent laparoscopic or robotic resection (January 2014 to January 2024) were retrospectively identified from two GIST centers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!